Based in Canada, Fusion Pharma is a startup.
Fusion Pharma develops targeted alpha therapeutics by connecting alpha emitting isotopes to molecules that selectively target cancer cell biomarkers, using proprietary Fast-Clear™ technology to improve safety and enable scalable manufacturing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.